Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A One Week Double-Blind, Randomized, Placebo-Controlled, Parallel Group, Multi-Center Study With Creon 40,000 MMS in Subjects With Pancreatic Exocrine Insufficiency Due to Chronic Pancreatitis, Followed by an Open-Label Long-Term Extension

NCT00705978 is registered in ClinicalTrials.gov with Abbott Products as lead sponsor.

NCT NCT00705978
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00705978 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A One Week Double-Blind, Randomized, Placebo-Controlled, Parallel Group, Multi-Center Study With Creon 40,000 MMS in Subjects With Pancreatic Exocrine Insufficiency Due to Chronic Pancreatitis, Followed by an Open-Label Long-Term Extension
Lead sponsor
Abbott Products
Phase
Phase 3
Overall status
Completed
Start date
June 30, 2008
Completion date
May 31, 2010
Enrollment
62 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

pancreatic insufficiency